Sign in
4

Changes in Ownership

BIOLARGO, INC. Filed Acc 0001437749-19-001055

Options or other derivatives

  • Chief Financial Officer acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
DARGAN CHARLES K Chief Financial Officer 2019-01-16 Grant or award · Stock Option Agreement +300,000 3,206,000 D
Loading xslF345X03/rdgdoc.xml…